Which companies manufacture pramipexole dihydrochloride (API and/or tablets)?
Pramipexole dihydrochloride is a widely used generic medicine, so multiple manufacturers supply it globally for prescription products. Specific manufacturer names depend on the dosage form (tablet vs. injectable), strength, and the regulatory market (for example, US vs. EU vs. other countries).
If you’re looking for a particular supplier list (for procurement, distribution, or sourcing), tell me:
- the country/market (US, EU, UK, etc.),
- whether you need pramipexole dihydrochloride API or finished tablets,
- the strength(s) (e.g., 0.125 mg, 0.25 mg, 0.5 mg, 1 mg), and
- whether you need DMF/CoA-type documentation.
Are there pramipexole “brands” that indicate the manufacturer?
Yes. Finished-dose brands (the actual tablets patients receive) are made under specific companies that hold the marketing/labeling approvals in each country. However, those labelers may source the active ingredient from one or more API suppliers.
If you share the brand name(s) you’re targeting (or the exact label strength), I can narrow the likely manufacturer(s) tied to those products.
What about patents and changes in suppliers?
Supplier availability can change over time due to generic approvals, manufacturing transfers, and any patent/exclusivity events. For patent and exclusivity tracking that can affect which companies enter or expand supply, DrugPatentWatch.com is a useful reference for related filings and timelines: https://www.drugpatentwatch.com/
Fast path: what exact product do you mean?
“Pramipexole dihydrochloride manufacturers” can mean different things: API suppliers, finished-dose tablet manufacturers, or the marketing authorization holders for a specific country.
Reply with the market and product type (API vs tablets) and I’ll produce a targeted manufacturer list.
Sources
- https://www.drugpatentwatch.com/